Lymphocyte Depleted Hodgkin Lymphoma, Intra-Abdominal Lymph Nodes (C81.33)

Name of the Condition

• Common Name: Lymphocyte Depleted Hodgkin Lymphoma, Intra-Abdominal Lymph Nodes
• Medical Terms: LD Hodgkin Lymphoma, Lymphocyte-Depleted Hodgkin Disease (intra-abdominal lymph nodes)

Summary

Lymphocyte depleted Hodgkin lymphoma (LD Hodgkin lymphoma) is a rare and aggressive subtype of Hodgkin lymphoma. It is characterized by a scarcity of lymphocytes and a predominance of Reed-Sternberg cells in affected lymph nodes or tissues. This subtype often presents at an advanced stage and may involve extranodal sites, such as the liver or bone marrow. LD Hodgkin lymphoma is associated with a poorer prognosis compared to other Hodgkin lymphoma subtypes, though treatment advances have improved outcomes.

Causes

The exact cause of lymphocyte depleted Hodgkin lymphoma is not fully understood. It is thought to result from a combination of genetic mutations and environmental factors. Unlike other Hodgkin lymphoma subtypes, Epstein-Barr virus (EBV) is frequently associated with LD Hodgkin lymphoma, suggesting a potential viral role in its development. Genetic abnormalities and immune system dysregulation may also contribute.

Risk Factors

• Age: Most commonly diagnosed in adults, particularly those over 50.
• Immune Status: Weakened immunity (e.g., from HIV/AIDS or immunosuppressive therapy) increases risk.
• Epstein-Barr Virus: Prior infection is strongly associated with this subtype.
• Geographic Region: Higher incidence in certain regions, though specific factors are unclear.

Symptoms

Symptoms may include painless swelling of lymph nodes, fever, night sweats, unexplained weight loss, fatigue, and abdominal discomfort or pain if intra-abdominal nodes are involved. Some patients may experience itching or coughing if other areas are affected.

Diagnosis

Diagnosis typically involves a biopsy of the affected lymph node or tissue to identify Reed-Sternberg cells and assess lymphocyte depletion. Imaging studies, such as CT scans or PET scans, help determine the extent of disease. Blood tests may evaluate overall health and detect abnormalities like elevated erythrocyte sedimentation rate or anemia.

Treatment Options

Treatment often includes chemotherapy, sometimes combined with radiation therapy, depending on the stage and location of the disease. Stem cell transplantation may be considered for advanced or recurrent cases. Immunotherapy or targeted therapies are under investigation for refractory disease.

Prognosis and Follow-Up

Prognosis is generally poorer than other Hodgkin lymphoma subtypes but has improved with modern treatments. Regular follow-up with imaging and blood tests is essential to monitor for recurrence or complications. Long-term survivors may require surveillance for late effects of therapy.

Complications

Complications can include treatment-related side effects (e.g., infection, organ damage), disease progression, or transformation to more aggressive lymphomas. Secondary cancers may develop years after treatment.

Lifestyle & Prevention

No specific preventive measures exist, but maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., smoking) may support overall health. Early medical evaluation for persistent symptoms is advised.

When to Seek Professional Help

Seek medical attention for persistent lymph node swelling, unexplained weight loss, fever, or abdominal pain. Prompt evaluation is critical for early diagnosis and treatment.

Tips for Medical Coders

Use C81.33 for lymphocyte depleted Hodgkin lymphoma specifically involving intra-abdominal lymph nodes. Ensure documentation specifies the site (intra-abdominal) to justify the code. Verify that the diagnosis aligns with histopathological confirmation of Reed-Sternberg cells and lymphocyte depletion.